Alembic Pharmaceuticals Ltd
Priti Patel is a skilled pharmaceutical professional with extensive experience in the research and development sector. Currently serving as a Senior Research Scientist at Alembic Pharmaceuticals Limited since February 2019, Priti previously held positions as a Junior Executive at Baxter Pharmaceuticals, a Research and Development Officer at Lincoln Pharmaceuticals Ltd, and an R&D Officer at Jenburkt Pharmaceuticals Ltd. Priti's educational background includes a Master's Degree in Pharmaceutical Technology from Parul Institute of Pharmacy and a Bachelor's Degree in Pharmacy from Sigma Institute of Pharmacy.
This person is not in the org chart
This person is not in any offices
Alembic Pharmaceuticals Ltd
8 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.